Scholarlink

Background <p>Chronic Insomnia Disorder (CID) is a prevalent condition. This study examines microbaric oxygen therapy (MOT) as a non-pharmacological intervention for CID patients, utilizing EEG to investigate its effects on neural mechanisms and provide novel electrophysiological evidence.</p> Method <p>In this longitudinal non-randomized study, CID patients from a tertiary hospital were allocated to oxygen therapy (OT) or non-oxygen therapy (NOT) groups. The OT group received daily 45-minute MOT sessions combined with pharmacotherapy, while the NOT group received pharmacotherapy alone. Assessments at baseline, week 1, and week 5 evaluated sleep quality, mood, cognition, and high-density EEG parameters including microstates, event-related potentials, and time-frequency features. Statistical analyses employed t-tests/Mann-Whitney U, chi-square/Fisher’s tests, and repeated-measures ANOVA with sphericity correction.</p> Results <p>The study included 40 OT and 38 NOT participants. Eye-closed resting EEG microstate analysis indicated that OT led to shorter microstate D duration, increased microstate C occurrence and contribution, decreased microstate D contribution, and altered transition probabilities. Quantitative analysis of the task-related time-frequency data showed that enhanced theta (4–8&#xa0;Hz) and alpha (8–13&#xa0;Hz) power during inhibition and a posterior beta (13–20&#xa0;Hz) shift, suggesting improved conflict monitoring and resource allocation. However, conventional ERP analysis did not reveal any significant between-group differences.</p> Conclusions <p>MOT induces clinically meaningful electrophysiological changes in CID patients, as evidenced by reduced resting-state microstate D (linked to hyper-arousal) and enhanced task-related theta/alpha power (reflecting improved conflict monitoring). This pattern suggests a shift from maladaptive hyper-vigilance toward more efficient cognitive control. These findings provide novel electrophysiological evidence for the neural basis of insomnia-related cognitive impairment and support its further development as a complementary therapeutic strategy.</p> Trial registration <p>ClinicalTrials. ChiCTR2300072452. Registered on June 14, 2023.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Microbaric oxygen therapy modulates EEG microstates and spectral power in patients with chronic insomnia disorder

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月21日

查看全文
  • Yixin Zhao,
  • Yongyan Shi,
  • Yihui Zhang,
  • Xuan Ouyang,
  • Shiqi Yuan,
  • Huili Guo,
  • Zebo Kuang,
  • Weilong Guo,
  • Liwen Tan

摘要

Background

Chronic Insomnia Disorder (CID) is a prevalent condition. This study examines microbaric oxygen therapy (MOT) as a non-pharmacological intervention for CID patients, utilizing EEG to investigate its effects on neural mechanisms and provide novel electrophysiological evidence.

Method

In this longitudinal non-randomized study, CID patients from a tertiary hospital were allocated to oxygen therapy (OT) or non-oxygen therapy (NOT) groups. The OT group received daily 45-minute MOT sessions combined with pharmacotherapy, while the NOT group received pharmacotherapy alone. Assessments at baseline, week 1, and week 5 evaluated sleep quality, mood, cognition, and high-density EEG parameters including microstates, event-related potentials, and time-frequency features. Statistical analyses employed t-tests/Mann-Whitney U, chi-square/Fisher’s tests, and repeated-measures ANOVA with sphericity correction.

Results

The study included 40 OT and 38 NOT participants. Eye-closed resting EEG microstate analysis indicated that OT led to shorter microstate D duration, increased microstate C occurrence and contribution, decreased microstate D contribution, and altered transition probabilities. Quantitative analysis of the task-related time-frequency data showed that enhanced theta (4–8 Hz) and alpha (8–13 Hz) power during inhibition and a posterior beta (13–20 Hz) shift, suggesting improved conflict monitoring and resource allocation. However, conventional ERP analysis did not reveal any significant between-group differences.

Conclusions

MOT induces clinically meaningful electrophysiological changes in CID patients, as evidenced by reduced resting-state microstate D (linked to hyper-arousal) and enhanced task-related theta/alpha power (reflecting improved conflict monitoring). This pattern suggests a shift from maladaptive hyper-vigilance toward more efficient cognitive control. These findings provide novel electrophysiological evidence for the neural basis of insomnia-related cognitive impairment and support its further development as a complementary therapeutic strategy.

Trial registration

ClinicalTrials. ChiCTR2300072452. Registered on June 14, 2023.